Abstract
Background ADHD polygenic scores (PGS) are reliably predictive of ADHD outcomes across studies. However, traditional PGS are statistical indices of genetic liability – predictive of ADHD but uninformed by biological information. The objective of our study was to determine whether a novel, biologically-informed, functionally annotated ADHD PGS can reveal specific brain mechanisms of risk for ADHD.
Methods Data were from the Philadelphia Neurodevelopmental Cohort (n=555). Multiple mediation models were tested to examine the indirect effects of ADHD PGS (including one using a functionally annotated approach, i.e., AnnoPred) on ADHD inattention (IA) and hyperactivity-impulsivity (HI) symptoms, via gray matter volumes in the cingulate gyrus, angular gyrus, caudate, dorsolateral prefrontal cortex (DLPFC), and inferior temporal lobe. Age-stratified analyses (children, adolescents, and young adults) were also conducted to account for developmental differences.
Results A direct effect was detected between AnnoPred PGS and IA symptoms in adolescents only. No indirect effects via brain volumes were detected for either IA or HI symptoms. However, ADHD PGS were consistently associated with the DLPFC.
Conclusions A biologically-informed PGS yielded a more powerful (and developmentally-specific) signal in detecting a direct effect of ADHD PGS on adolescent IA symptoms. However, no indirect effects between ADHD PGS and ADHD symptomology via the brain emerged. ADHD will become increasing predictive as discovery sample sizes climb. Studies that integrate both genetic and neuroimaging information are critical to advancing our understanding of the biological mechanisms underlying ADHD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported in part by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P50HD105353).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used in this study are publicly available in dbGaP (https://www.ncbi.nlm.nih.gov/gap/). Study scripts and codebooks to query and process the symptom-level data can be accessed on our study preregistration via the Open Science Framework: https://osf.io/whjuq
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations
Ethics approval and consent to participate PNC is a publicly available, de-identified dataset. Thus, this study was exempt from requiring approval from the University of Wisconsin-Madison Health Sciences Institutional Review Board (see “Category 4” exemption: https://kb.wisc.edu/gsadminkb/page.php?id=29465).
Consent for publication Not applicable
Availability of data and materials The data used in this study are publicly available in dbGaP (https://www.ncbi.nlm.nih.gov/gap/). Study scripts and codebooks to query and process the symptom-level data can be accessed on our study preregistration via the Open Science Framework: https://osf.io/whjuq
Funding This study was supported in part by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P50HD105353). Q.H. was also supported by a Wisconsin Distinguished Graduate Fellowship from the Waisman Center.
Competing interests The authors declare no competing interests
Author information Quanfa He, qhe37{at}wisc.edu
Taylor Keding, tjkeding{at}gmail.com
Qi Zhang, qzhang384{at}wisc.edu
Jiacheng Miao, jmiao24{at}wisc.edu
Ryan J. Herringa, herringa{at}wisc.edu
Qiongshi Lu, qlu{at}biostat.wisc.edu
Brittany G. Travers, btravers{at}wisc.edu
James J. Li, james.li{at}wisc.edu
Data Availability
The data used in this study are publicly available online in dbGaP (https://www.ncbi.nlm.nih.gov/gap/).
Abbreviations
- ADHD
- attention deficit hyperactivity disorder
- CFI
- Comparative Fit Index
- DLPFC
- dorsolateral prefrontal cortex
- GWAS
- genome-wide association study
- HI
- hyperactivity-impulsivity
- IA
- inattention
- PGS
- polygenic score
- RMSEA
- Root Mean Square Error of Approximation